General
Preferred name
prednisone
Synonyms
Prednisone (Adasone) ()
Prednisone53-03-2 ()
Dehydrocortisone ()
Adasone,NSC-10023 ()
Prednisone (NSC-10023) ()
Deltasone ()
Metacortandracin ()
3en3hg4wsw ()
Prednicen-M ()
Decortin ()
Prednisone anhydrous ()
Prednisone tablets ()
Delta-Dome ()
Orasone ()
Rayos ()
Lodotra ()
Prednisone Intensol ()
Meticorten ()
Supercortil ()
NSC-10023 ()
Paracort ()
Liquid Pred ()
Fernisone ()
Prednisona ()
Servisone ()
Sterapred ()
Decortisyl ()
Cortan ()
Cortancyl ()
Prednisone-d7 ()
P&D ID
PD002901
CAS
13479-38-4
53-03-2
Tags
available
prodrug
drug
Approved by
FDA
First approval
1955
Drug indication
Nasal Cavity Polyp
Eczema
Atopic dermatitis
Inflammation
Drug Status
vet_approved
approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Prednisone is a synthetic corticosteroid. (GtoPdb)
PRICE 29
DESCRIPTION Prednisone (Adasone) is a corticosteroid agent with anti-inflammatory and immunosuppressive effects that can be used to study diseases related to systemic lupus erythematosus[1][2].
DESCRIPTION Prednisone (Dehydrocortisone) is a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.
DESCRIPTION Prednisone is a corticosteroid used to treat inflammation or immune-mediated reactions. (Enamine Bioactive Compounds)
Cell lines
1
Organisms
0
Compound Sets
22
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
External IDs
59
Properties
(calculated by RDKit )
Molecular Weight
358.18
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
4
Aromatic Ring Count
0
cLogP
1.77
TPSA
91.67
Fraction CSP3
0.67
Chiral centers
6.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Disease Area
endocrinology, rheumatology, infectious disease, dermatology, ophthalmology, hematology, gastroenterology, neurology/psychiatry
Indication
congenital adrenal hyperplasia, hypercalcemia, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, bursitis, osteoarthritis, epicondylitis, dermatomyositis, psoriasis, mycosis, conjunctivitis, anemia, ulcerative colitis, enteritis, multiple sclerosis, meningitis
Target
HSD11B1, NR3C1
Apoptosis
Glucocorticoid Receptor
Glucocorticoid Receptor,Immunology & Inflammation related
MOA
Glucocorticoid Receptor agonist
Therapeutic Class
Antiinflammatory Agents
Pathway
Immunology/Inflammation
Vitamin D Related/Nuclear Receptor
Source data